Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age

NCT05096208 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1028

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV

Interventions

BIOLOGICAL: RSVpreF (Group 1)
BIOLOGICAL: RSVpreF (Group 2)
BIOLOGICAL: RSVpreF (Group 3)
BIOLOGICAL: Placebo

Sponsor

Pfizer